The clinical value and most informative threshold of polygenic risk score in the Quebec City Case-Control Asthma Cohort
Abstract Genome-wide association studies (GWAS) have identified genetic variants robustly associated with asthma. A potential near-term clinical application is to calculate polygenic risk score (PRS) to improve disease risk prediction. The value of PRS, as part of numerous multi-source variables use...
Saved in:
Main Authors: | Martin Pariès, Stéphanie Bougeard, Aida Eslami, Zhonglin Li, Michel Laviolette, Louis-Philippe Boulet, Evelyne Vigneau, Yohan Bossé |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-025-03486-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polygenic diseases
by: Sergey Dolomatov, et al.
Published: (2025-01-01) -
Polygenic prediction of human longevity on the supposition of pervasive pleiotropy
by: M. Reza Jabalameli, et al.
Published: (2024-08-01) -
Risk factors affecting polygenic score performance across diverse cohorts
by: Daniel Hui, et al.
Published: (2025-01-01) -
Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening
by: Georgina L Hollitt, et al.
Published: (2025-01-01) -
Enhancing the utility of polygenic scores in Alzheimer’s disease through systematic curation and annotation
by: Savannah Mwesigwa, et al.
Published: (2025-02-01)